
Cameron Fyfe
CO-FOUNDER & CEO
As CEO, Cameron sets Synanthra's strategic direction, turning frontier science into a staged commercial roadmap and building the team, partnerships, and funding to deliver it.
He is also an expert in bioelectrochemistry and nitrogenase biology, the enzyme family at the heart of Synanthra's technology. He holds a PhD in biochemistry and microbiology and is first author of multiple papers in Nature and Nature Chemical Biology, most recently a November 2025 article on biological nitrogen fixation.
LinkedIn